Overview

AZD3293 Thorough QT Study in Healthy Male Volunteers

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
A thorough QT study of AZD3293
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel
Treatments:
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Pharmaceutical Solutions